We are developing personalized, artificial intelligence (AI) based, voice monitoring that turns smart devices into remote patient monitoring devices for voice-affecting diseases such as asthma*, pneumonia* and COPD**. Healthymize automates labor intensive phone monitoring typically in place to prevent readmissions and manage chronic patients, giving clinicians the ability to assess the voice of the patient at any time.
Our goal is to monitor the progression of these diseases wherever and whenever patients speak on their smartphones. Healthymize analyzes voice samples from the patient aiming to identify the onset of flare ups. When a flare up is detected, the Healthymize system could alert medical teams to enable early treatment of patients at home, keeping them where they feel most comfortable.
The Potential Benefits
Prevent condition from worsening by predicting flare ups
Save time, anguish, and money by reducing hospital visits
Health care providers
Detect flare ups earlier and administer treatment to prevent deterioration
Improve coordination and delivery of care
Save costs of hospitalization
Partner with us
Our diverse team is composed of experienced individuals who work passionately to improve the lives of chronic patients. As a growing company, we value collaboration with others that have a similar vision.
Healthymize will offer its voice analysis for integration into remote patient monitoring systems. Our goal is to provide a voice monitoring solution for home care, chronic care management and readmission preventions.
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease that restricts lung airflow. Patients suffer from flare-ups that are characterized by shortness of breath, coughs, and sputum production.
Delayed diagnosis and treatment of these flare-ups often results in severe exacerbations requiring hospitalization.
The overall prevalence of COPD in the general population is more than 5%.
Prevalence increases with age, reaching about 10% among adults between 75-84 years old.
In 2010, the overall cost of COPD in the US was $36 billion and is estimated to reach $49 billion by 2020. Costs due to COPD-related care are driven primarily by hospitalizations.
We are always looking for talented people to join our team. We would not be successful without our awesome team of dedicated people. If you are talented and have got the desire to be a part of a creative and innovative group of people in a fun and rewarding environment, then please send your resume to email@example.com and we will get in touch with you.